BESPONSA

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: f5023247467f0b11
Drug Approval Canada Name: BESPONSA
Product Name: BESPONSA
Status: Marketed
Status Date: 2018-05-03
Original Market Date: 2018-05-03
Din: 02473909
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Prescription , Schedule D
Ahfs: 10:00.00
Atc Original: L01FB01 INOTUZUMAB OZOGAMICIN
Atc Name: l 01 fb 01
Aig Number: 0160110001
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

INOTUZUMAB OZOGAMICIN

0.9 MG / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

f5023247467f0b11

Type

Standard